Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Xi'an
Clinical trial register · China

Clinical Trials in Xi'an, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19212 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:17 UTC
19212
Studies in scope
all four open statuses
11805
Recruiting now
open to new participants
2029
Lead sponsors
across recruiting studies
Top sites
Xi'an 120 Yan’an 9 Xianyang 8 Lanzhou 7 Yinchuan 7
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Xijing Hospital123 Tang-Du Hospital50 First Affiliated Hospital Xi'an Jiaotong University41 Xijing Hospital of Digestive Diseases19 Air Force Military Medical University, China17 Clear sponsor filter
Site location
Xi'an120 Yan’an9 Xianyang8 Lanzhou7 Yinchuan7
All 38 locations
Target enrolment
to

Trials with a site in Xi'an

123 of 19212 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Xijing Hospital
Observational
100
Xi'an
2026-08-25
Recruiting
Xijing Hospital
Observational
5,000
Zhaoqing, Xi'an, Jinan, Mianyang, Wuwei, Wuxi
2026-08-10
Recruiting
Xijing Hospital
Not applicable
500
Xi'an
2026-08-10
Recruiting
Xijing Hospital
Observational
5,000
Xi'an, Dalian, Hami, Heze, Jinan, Langfang, Liu‘an, Qingdao
2026-08-10
Recruiting
Xijing Hospital
Not applicable
24
Xi'an
2026-08-01
Recruiting
Xijing Hospital
Phase 2
120
Xi'an
2026-07-01
Not yet open
Xijing Hospital
Not applicable
98
Xi'an
2026-07-01
Not yet open
A Real-world HCM-cohort Trial
NCT07638033Hypertrophic Cardiomyopathy (HCM)
Xijing Hospital
Observational
3,000
Xi'an
2026-06-30
Not yet open
Xijing Hospital
Observational
20
Xi'an
2026-05-31
Recruiting
Xijing Hospital
Phase 2
34
Xi'an
2026-05-29
Recruiting
Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple Sclerosis
NCT07587125Multiple Sclerosis (MS) Primary Progressive, Multiple Sclerosis, Multiple Sclerosis (MS) Secondary Progressive, Refractory Multiple Sclerosis
Xijing Hospital
Phase 1
9
Xi'an
2026-05-08
Active, closed
Radar Sleep Monitoring in Type 1 Narcolepsy: Feasibility
NCT07654803Narcolepsy Type 1 (NT 1), Hypersomnolence Disorder
Xijing Hospital
Observational
1
Xi'an
2026-05-07
Active, closed
Xijing Hospital
Not applicable
240
Xi'an
2026-05-03
Recruiting
Transcutaneous Electrical Acupoint Stimulation at Jing-Well Points for Disorders of Consciousness
NCT07535593Disorders of Consciousness Due to Severe Brain Injury
Xijing Hospital
Phase 2/3
160
Xi'an
2026-04-20
Recruiting
Picankibart in Palmoplantar Pustulosis
NCT07552454Palmoplantar Pustulosis
DrugPicankibart
Xijing Hospital
Not applicable
60
Xi'an
2026-04-15
Not yet open
Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo
NCT07519031Vitiligo, Mesenchymal Stem Cells, Exosomes
DrugsTacrolimus·Prednisone
Xijing Hospital
Phase 1/2
96
Xi'an
2026-04
Recruiting
Xijing Hospital
Not applicable
428
Xi'an
2026-03-30
Not yet open
Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer
NCT07466303Breast Cancer, Serplulimab Combined With SHR-A1811 as Neoadjuvant Therapy for Triple-Negative Breast Cancer
DrugsTrastuzumab Rezetecan·Serplulimab
Xijing Hospital
Phase 2
84
Xi'an
2026-03-25
Recruiting
Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis
NCT07553754Prostate Cancer (Diagnosis), Bone Metastasis, PSMA PET, Liquid Biopsy
Xijing Hospital
Observational
1,000
Lanzhou, Yinchuan, Weinan, Xi'an, Xianyang, Xining, Yan’an
2026-03-12
Recruiting
Xijing Hospital
Observational
1,000
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2026-03-03
Recruiting
Sodium Aescinate for the Treatment of Low Back Pain (LBP) in Adults
NCT07339631Low Back Pain, Paraspinal Muscle, CLBP - Chronic Low Back Pain, Non-specific Chronic Low Back Pain
Xijing Hospital
Phase 1
40
Xi'an
2026-03-01
Recruiting
Xijing Hospital
Observational
180
Xi'an
2026-02-05
Recruiting
Transcutaneous Electrical Nerve Stimulation (TENS) for the Treatment of Low Back Pain (LBP) in Adults
NCT07368920Low Back Pain, Paraspinal Muscles, CLBP - Chronic Low Back Pain
Xijing Hospital
Not applicable
40
Xi'an
2026-02-01
Active, closed
Xijing Hospital
Early Phase 1
1
Xi'an
2026-01-31
Not yet open
Xijing Hospital
Not applicable
60
Xi'an
2026-01-20
Recruiting
Study on the Cosmetic Outcome and Safety Evaluation of 3D Printed Biodegradable Biological Mesh for One-Stage Breast Reconstruction After Radical Mastectomy
NCT07365267Breast Cancer, Breast Reconstruction After Mastectomy, 3D-Printed Biodegradable Biological Mesh
Xijing Hospital
Not applicable
25
Xi'an
2026-01-15
Active, closed
Exemption of SLNB After Neoadjuvant Therapy for Triple-negative and Her2-positive Breast Cancer
NCT07498400Breast Cancer (Triple Negative Breast Cancer (TNBC)), Breast Cancer
Xijing Hospital
Not applicable
216
Xi'an
2026-01-01
By invitation
Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices
NCT07352228Rebleeding of Portal Hypertension in Liver Cirrhosis, Propranolol, Carvedilol
DrugsCarvedilol·Propranolol
Xijing Hospital
Phase 4
350
Xi'an
2026-01-01
By invitation
Continuous HRV Monitoring for Predicting Response to Biologic Therapy in IBD
NCT07475052Inflammatory Bowel Disease, Heart Rate Variability, Biologics, Prediction
Xijing Hospital
Observational
100
Xi'an
2025-12-25
Not yet open
Xijing Hospital
Observational
125
Xi'an
2025-12-23
Recruiting
Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions
NCT07022587De Novo Stenosis, Coronary Artery Disease
Xijing Hospital
Not applicable
2,000
Xi'an
2025-12-20
By invitation
Application of an AI-Based Health Management System in Long-Term Epilepsy Management in Rural Areas
NCT07448233Epilepsies, Remote Management of Epilepsy in Rural Areas
Xijing Hospital
Not applicable
20
Xi'an
2025-12-01
Not yet open
Xijing Hospital
Observational
1,630
Xi'an
2025-12-01
Recruiting
Xijing Hospital
Not applicable
3
Xi'an
2025-11-17
Recruiting
Xijing Hospital
Phase 1
30
Xi'an
2025-11-06
Recruiting
Xijing Hospital
Observational
1,500
Xi'an
2025-10-31
Recruiting
Desflurane vs. Propofol for Cardiac Anesthesia
NCT07116733Cardiac Surgery, Coronary Artery Bypass Grafting
Xijing Hospital
Phase 3
3,560
Fuzhou, Cangzhou, Shijiazhuang, Zhengzhou, Wuhan, Nanjin, Xi'an, Chengdu
2025-10-20
Recruiting
Xijing Hospital
Phase 1/2
20
Xi'an
2025-10-01
Recruiting
Xijing Hospital
Not applicable
60
Xi'an
2025-10-01
Recruiting
Xijing Hospital
Phase 2
34
Xi'an
2025-09-25
Not yet open
Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock
NCT07129031Hemorrhage, Hemorrhagic Shock, Upper Gastrointestinal Bleeding (UGIB)
Xijing Hospital
Phase 3
180
Xi'an
2025-09-01
Not yet open
Xijing Hospital
Observational
150
Xi'an
2025-08-31
Recruiting
Study on the Preferences for PCI Implantation Devices Among Doctors and Patients
NCT07378163Coronary Artery Disease, Percutaneous Coronary Intervention
Xijing Hospital
Observational
600
Xi'an
2025-08-18
Recruiting
Comparing the Components of Composite Endpoints for Healthcare Providers and Patients
NCT07378137Coronary Artery Disease, Percutaneous Coronary Intervention
Xijing Hospital
Observational
600
Xi'an
2025-08-18
Not yet open
Xijing Hospital
Not applicable
10
Xi'an
2025-08-15
Not yet open
Xijing Hospital
Not applicable
140
Xi'an
2025-08-15
Recruiting
Xijing Hospital
Not applicable
60
Xi'an
2025-08-02
Recruiting
Xijing Hospital
Not applicable
15
Xi'an
2025-08-02
By invitation
Xijing Hospital
Not applicable
354
Xi’an
2025-07-30
Active, closed
Xijing Hospital
Not applicable
120
Xi'an
2025-07-18
Recruiting
Xijing Hospital
Observational
200
Xi'an
2025-07-01
Recruiting
Xijing Hospital
Not applicable
1,200
Xi'an
2025-06-20
Not yet open
Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies
NCT07014254Pancreatic Ductal Adenocarcinoma (PDAC), Adenocarcinoma of the Stomach, Colorectal Cancer Metastatic, Neuroendocrine Tumor (NET)
Xijing Hospital
Not applicable
20
Xi'an
2025-06-20
Not yet open
Xijing Hospital
Not applicable
69
Xi'an
2025-06-15
Recruiting
Xijing Hospital
Phase 2
27
Xi'an
2025-06-05
By invitation
Exploration and Establishment of an Early Warning System for Futile Reperfusion - A I S
NCT07045987Acute Ischemic Stroke (AIS), Endovascular Thrombectomy, Neurovascular Unit- Brain Lymphatic System
Xijing Hospital
Observational
2,000
Xi’an
2025-06-01
Recruiting
Xijing Hospital
Observational
150
Xi'an
2025-05-26
Recruiting
Xijing Hospital
Observational
300
Wuwei, Shantou, Zhaoqing, Zhengzhou, Xi'an, Yan’an, Taiyuan, Chengdu
2025-05-26
Not yet open
Xijing Hospital
Observational
200
Xi'an
2025-05-25
Recruiting
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
NCT06702553Nitric Oxide, Cardiac Surgery, Cardiopulmonary Bypass, Adult Patients Undergoing Cardiovascular Surgery With Cardiopulmonary Bypass
Xijing Hospital
Phase 3
3,650
Xi'an
2025-05-19
Recruiting
Xijing Hospital
Early Phase 1
10
Xi'an
2025-05-01
Recruiting
3D-printed Biodegradable Breast Implants for Breast Restoration
NCT06993714Breast Cancer, Breast Reconstruction
Xijing Hospital
Phase 2
120
Xi'an
2025-05-01
Active, closed
Xijing Hospital
Observational
800
Xi'an
2025-04-29
Recruiting
Xijing Hospital
Observational
450
Xi'an, Chengdu, Beijing, Shanghai
2025-04-24
By invitation
Sulodexide in Controlling the Recurrence of Psoriasis
NCT06982196Psoriasis (PsO), Randomised Controlled Trial
DrugSulodexide
Xijing Hospital
Phase 3
160
Xi'an
2025-04-20
Recruiting
Transcranial Temporal Interference Stimulation In Severely Brain Injured Patients With Disorders of Consciousness
NCT06851156Disorders of Consciousness, Severe Brain Injury, Unresponsive Wakefulness Syndrome, Minimally Conscious State
Xijing Hospital
Not applicable
10
Xi'an
2025-04-07
Recruiting
Xijing Hospital
Not applicable
90
Xi'an
2025-04-01
Not yet open
PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique
NCT06914427Prostatic Neoplasms, Glioma, PARKINSON DISEASE (Disorder)
Xijing Hospital
Not applicable
35
Xi'an
2025-03-28
Not yet open
Long Term Efficacy and Safety of TMS Targeting Cerebellum to Treat DRE
NCT06832813Drug-resistant Epilepsy, Transcranial Magnetic Stimulation
Xijing Hospital
Not applicable
100
Xi'an
2025-03-28
Active, closed
Xijing Hospital
Not applicable
177
Xi'an
2025-03-18
Active, closed
Xijing Hospital
Not applicable
99
Xi'an
2025-03-10
Recruiting
The Feasibility of taVNS on Pregnancy Outcomes of Infertility Patients Undergoing IVF
NCT06742788Infertility Assisted Reproductive Technology
Xijing Hospital
Not applicable
90
Xi'an
2025-03-04
Not yet open
Xijing Hospital
Not applicable
30
Xi'an
2025-03-01
Recruiting
Xijing Hospital
Not applicable
158
Xi'an
2025-02-20
Not yet open
Optimal LDL-C Target in High-risk Patients After PCI
NCT06821711Chronic Coronary Syndrome, Acute Coronary Syndromes, Percutaneous Coronary Intervention, High Risk Patient
Xijing Hospital
Not applicable
12,000
Xi'an
2025-02-20
Active, closed
Xijing Hospital
Not applicable
10
Xi'an
2025-02-10
Active, closed
Xijing Hospital
Not applicable
65
Xi'an
2025-02-10
Recruiting
Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases （ACT-AD）
NCT06669182Alzheimer Disease, Transcranial Magnetic Stimulation, Cerebellum
Xijing Hospital
Not applicable
100
Xi'an
2025-01-07
Recruiting
Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer
NCT06613165Immune-related Adverse Event, Neoadjuvant Therapy, dMMR Colorectal Cancer
Xijing Hospital
Observational
100
Xi'an
2025-01-01
Recruiting
Xijing Hospital
Observational
146
Xi'an
2025-01-01
Not yet open
Xijing Hospital
Phase 2/3
340
Xi'an
2024-12-31
Active, closed
Xijing Hospital
Phase 2
116
Shijiazhuang, Xi'an, Tianjin
2024-11-15
Recruiting
Xijing Hospital
Not applicable
40
Xi'an
2024-10-18
Recruiting
Xijing Hospital
Phase 2
18
Xi'an
2024-10-16
Not yet open
Preoperative Risk Evaluation and Per ERAS Intervention in the Chinese Elderly Patients Underwent Spinal Fusion Surgery
NCT06607081Degenerative Spinal Disease, Elderly Patients, Spinal Fusion Acquired
Xijing Hospital
Not applicable
5,000
Xi'an
2024-10-15
Recruiting
Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients
NCT07180368Coronary Artery Disease, Diabete Mellitus, Chronic Kidney Disease, Hypertension
Xijing Hospital
Observational
2,000
Xi'an
2024-10-01
Recruiting
Xijing Hospital
Not applicable
80
Xi'an
2024-07-01
Recruiting
Exploring the Characteristics of Epileptogenic Foci in Drug-Resistant Epilepsy Based on Multimodal Imaging Technology
NCT06557720Drug Resistant Epilepsy, Magnetic Resonance Imaging, Electroencephalogram (EEG)
Xijing Hospital
Observational
50
Xi'an
2024-06-11
Recruiting
Xijing Hospital
Phase 2
80
Xi’an
2024-05-01
Recruiting
Xijing Hospital
Not applicable
71
Xi'an
2024-04-01
Recruiting
Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis
NCT06359808Colitis, Ulcerative, Sleep Quality, Gastrointestinal Microbiome, Autonomic Nervous System Imbalance
Xijing Hospital
Observational
152
Xi'an
2024-04-01
By invitation
Xijing Hospital
Not applicable
320
Shanghai, Xi'an
2024-03-28
Recruiting
Xijing Hospital
Not applicable
40
Xi'an
2024-01-24
Recruiting
Xijing Hospital
Not applicable
96
Xi'an
2024-01-19
Recruiting
Xijing Hospital
Observational
3,000
Xi'an
2023-10-30
Recruiting
Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis
NCT06082531Platelets-rich Plasma, Osteoarthritis Knees Both, Meniscus Disorder, Cartilage Injury
DrugSodium Hyaluronate
Xijing Hospital
Not applicable
300
Xi'an
2023-09-01
Recruiting
The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric
NCT05956847Gastric Cancer, Precancerous Lesion of Digestive Tract, Extrachromosomal DNA
Xijing Hospital
Observational
1,000
Xi'an
2023-08-10
Recruiting
Xijing Hospital
Not applicable
15
Xi'an
2023-07-20
Recruiting
Xijing Hospital
Not applicable
4,220
Xi'an
2023-07-06
Recruiting
Xijing Hospital
Phase 2
194
Xi'an
2023-04-03
Active, closed
Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion (MIST-B)
NCT05512910Ischemic Stroke, Acute, Minocycline, Endovascular Treatment, Basilar Artery Occlusion
DrugMinocycline
Xijing Hospital
Phase 4
90
Xi'an
2023-03-04
Recruiting
Study of Individualized, Precise and Standardized Cervical Open-door Surgery for Cervical Spinal Stenosis
NCT05786313Cervical Spinal Stenosis, Cervical Spinal Cord Injury, Individuation, Standardization
Xijing Hospital
Not applicable
500
Xi'an
2023-03-01
Recruiting
Researching the Useful of Barb Suture in Obese Patients Undergoing Posterior Cervical Surgery
NCT05895968Cervical Spinal Stenosis, Posterior Cervical Spine Surgery, Barbed Suture
Xijing Hospital
Not applicable
60
Xi'an
2023-01-01
Recruiting
Xijing Hospital
Not applicable
500
Xi'an
2023-01-01
Active, closed
Xijing Hospital
Phase 2
31
Xi'an
2022-12-05
Not yet open
Xijing Hospital
Phase 1/2
48
Xi'an
2022-09-30
Recruiting
LAAO Versus NOAC in Patients with AF and PCI
NCT05353140Atrial Fibrillation, Percutaneous Coronary Intervention
DrugsRivaroxaban·Clopidogrel·Aspirin
Xijing Hospital
Not applicable
1,386
Xi'an
2022-09-01
Recruiting
Xijing Hospital
Not applicable
1,060
Xi'an
2022-05-16
Recruiting
Xijing Hospital
Observational
3,000
Ankang, Hanzhong, Xi'an, Ya'an, Yunlin, Xianyang, Yan’an
2022-03-01
Active, closed
1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated Balloon
NCT04971356Antiplatelet Drug, Acute Coronary Syndrome, Angioplasty, Balloon
Xijing Hospital
Not applicable
1,948
Xi'an
2021-11-01
Recruiting
68Ga-PSMA PET in the Renal Cell Carcinoma
NCT04987086Renal Cancer, Metastases, PSMA PET
Xijing Hospital
Not applicable
300
Lanzhou, Yinchuan, Xining, Xi'an, Weinan, Xianyang, Yan’an
2021-06-01
Recruiting
Xijing Hospital
Observational
1,700
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-12
By invitation
Xijing Hospital
Not applicable
1,600
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-12
Recruiting
Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer
NCT07553780High-risk Prostate Cancer, PSMA PET, Treatment Response, Therapy Monitoring
Xijing Hospital
Observational
110
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-07
Recruiting
Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer
NCT07531329Treatment-naive Prostate Cancer, Suspected Prostate Cancer, Molecular Imaging
Xijing Hospital
Observational
1,000
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-05
Active, closed
Xijing Hospital
Not applicable
2,272
Xi'an
2021-02-01
Active, closed
Xijing Hospital
Not applicable
10
Xi'an
2019-12-01
Recruiting
Xijing Hospital
Observational
668
Xi'an
2019-01-01
Recruiting
Xijing Hospital
Observational
500
Xi'an
2018-10-30
Recruiting
Long-term Prognosis and Valve Durability of TAVR
NCT06379386Aortic Valve Stenosis and Insufficiency
Xijing Hospital
Observational
1,000
Xi'an
2016-01
Active, closed
Drug-coated Balloons and Drug-eluting Stents in Diabetic Patients
NCT05937230Coronary Heart Disease, Angioplasty, Balloon
Xijing Hospital
Observational
1,500
Xi'an
2015-06-01
Recruiting
Xijing Hospital
Observational
30,000
Xi'an
2011-05-01
Recruiting
Colorectal Cancer Dataset in Xijing Hospital From 2011
NCT06308354Prognostic Cancer Model, Chemotherapy, Nutrition Related Cancer
Xijing Hospital
Observational
40,000
Xi'an
2011-01-01
Rows per page Showing 1–123 of 123
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 November 2026. https://priyalifescience.com/clinical-trials-china/city/xi-an

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,212 studies in total at the last sync on 10 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 123 of those studies with a site in Xi'an that also match the filters currently applied.

How many clinical trials are recruiting in Xi'an?

76 of the 123 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:17 UTC sync. A further 22 have not yet opened recruitment, 17 are active but closed to new participants, and 8 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Xi'an), 123 studies
PhaseStudiesRecruitingShare
Not applicable563145.5%
Observational402932.5%
Phase 21188.9%
Phase 3423.3%
Phase 1332.4%
Phase 1/2312.4%
Early Phase 1211.6%
Phase 2/3211.6%
Phase 4201.6%

Most active sponsors

Lead sponsors with the most studies (Xi'an)
Lead sponsorStudiesRecruiting
Xijing Hospital12376
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.